RZLT today
$3.87-$0.20 (-4.91%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $11.46
Key levels
Resistance$4.57
Resistance$4.21
Support$3.56
Support$3.18
Latest news & SEC filings
EarningsRezolute Posts Financials for Q1 of Fiscal 2027
DealRezolute Files Prospectus For $400M Mixed Shelf Offering
SEC FilingRezolute, Inc. filed a shelf registration for future offerings (Form S-3)
EarningsRezolute reports Q1 EPS of $(0.18), matching estimates
All RZLT news →About Rezolute
Rezolute is a clinical-stage biopharmaceutical company developing treatments for hypoglycemia caused by hyperinsulinism. Its lead candidate, ersodetug, is an intravenous antibody designed to reduce insulin receptor activity and is being studied in congenital hyperinsulinism and tumor-driven hyperinsulinism. The company also provides ersodetug through expanded access programs for patients with refractory hypoglycemia. It operates in the United States.
Based on the company's 10-K filed Sep 24, 2026.
Nasdaq · Healthcare
Rezolute, Inc. (RZLT)
What Is the Price Target for RZLT?
SEPT Low Target
$6.00
SEPT Mid Target
$11.00
SEPT High Target
$15.00
Analyst Consensus
$11.00
Is RZLT a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RZLT.
Start Free Trial →Is RZLT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$8.88
12
Moat Score
NONE
1/9
Piotroski Score
12.9
Altman Z-Score
What Is Smart Money Doing with RZLT?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Evans Daron | officer | Sale | 16,000 | - | Oct 21, 2026 |
| Evans Daron | officer | Buy | 4,000 | - | Oct 21, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RZLT Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
23.47%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for RZLT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RZLT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:21 | $3.87 | 7,700 | $$30K | SELL |
| 20:55:31 | $3.89 | 1,600 | $$6K | BUY |
| 20:54:17 | $3.89 | 2,400 | $$9K | SELL |
| 20:54:17 | $3.90 | 1,100 | $$4K | MIDPOINT |
| 20:51:27 | $3.91 | 1,000 | $$4K | BUY |
5 dark pool trades shown · $$54K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for RZLT
PREVIEWSEPT Investing provides real-time options flow tracking for RZLT, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Dec 18 | 36 | $$840 | 14 | SWEEP |
| CALL | $5 | Dec 18 | 36 | $$840 | 14 | SWEEP |
2 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Rezolute, Inc. (RZLT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RZLT — frequently asked questions
What is RZLT stock price today?
Rezolute, Inc. (RZLT) is at $3.87, down 4.91% (-$0.20) at the Nov 12, 2026 close.
Why is RZLT stock moving today?
Latest RZLT news — Nov 5, 2026: Rezolute Posts Financials for Q1 of Fiscal 2027 · Nov 5, 2026: Rezolute Files Prospectus For $400M Mixed Shelf Offering
Why did RZLT stock move on Oct 6, 2026?
Rezolute shares fell 6.90% today to close at $4.32, trading between a high of $4.64 and a low of $4.15 on volume of 2,172,712. Despite the decline, two analyst firms issued bullish updates: Lake Street maintained its Buy rating and raised its price target to $12, while Citizens maintained Market Outperform and raised its target to $15.
What is the RZLT price target?
The average analyst price target for RZLT is $11.00, ranging from $6 to $15, based on 7 analysts. Latest: Lake Street maintains on Oct 6, 2026.
What do analysts rate RZLT?
Analyst ratings for RZLT: 4 Buy, 9 Hold, 0 Sell — consensus Hold.
Did RZLT beat earnings?
RZLT last reported on Sep 24, 2026: EPS -$0.20 vs -$0.15 expected — a miss of 35.2%.
Does RZLT pay a dividend?
RZLT does not currently pay a dividend.
What are RZLT support and resistance levels?
Support: $3.56, $3.18, $2.83. Resistance: $4.21, $4.57, $4.91.
What are insiders doing with RZLT?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on RZLT?
Nov 5, 2026: Rezolute Posts Financials for Q1 of Fiscal 2027 · Nov 5, 2026: Rezolute Files Prospectus For $400M Mixed Shelf Offering · Nov 5, 2026: Rezolute, Inc. filed a shelf registration for future offerings (Form S-3)